Chris Hayter

[Chris Hayter @Marahayter]

Nothing to see here, 1.5% down. More patience required...
$crbu

[Chris Hayter @Marahayter]

@ahenryokc 2% down on the day so no big thing. More time to do a deal...

[Chris Hayter @Marahayter]

Still exploring funding options but positive is cash burn a lot lower than expected, now until the end of next year. Updated data in H2. They don't need to take a bad deal...
$crbu

[Chris Hayter @Marahayter]

@ahenryokc Disagree...maybe an immediate wobble based on people assuming they will get funding news but back to current level within 2 weeks...

[Chris Hayter @Marahayter]

@ahenryokc So you selling out on this news? The ATM facility is something we all knew was in place, for precisely this situation in Biotech. Just my opinion but I think the market will read this update as neutral at worst. It's very pleasible they strengthening their negotiation position

[Chris Hayter @Marahayter]

@Theoriatheoria Great insight

[Chris Hayter @Marahayter]

@ahenryokc I am seeing just under 5%? This is frustrating but you can't argue the company have a strategy. Streamline, conserve cash and focus on their best assets. Communication on the funding options has been terrible but they are doing a lot right. Hold

[Chris Hayter @Marahayter]

@ahenryokc Where did you get the 10% ?

[Chris Hayter @Marahayter]

@ahenryokc I'm intrigued but probably lean towards your thought, very neutral. Wondering if they will acknowledge the Pfizer expiry and add some colour around that. A hint of a partnership/direction would be nice !

[Chris Hayter @Marahayter]

@ahenryokc Is it definitely tonight?

[Chris Hayter @Marahayter]

@eurfc18 Lane in at LB and Marriott for Brown

[Chris Hayter @Marahayter]

@RFCLatest Randall left back

[Chris Hayter @Marahayter]

@Oscar_rfc1871 @catania_rick15 @ToddTrosclair @ReadingFC I would actually start Randall Williams left back, played there for Bolton

[Chris Hayter @Marahayter]

@Theoriatheoria Not me, they have cash runway until H2 next year and have a compelling RMAT status treatment (to people that would normally miss out) that will help 1000's, accompanied with excellent initial results. Not going to happen

[Chris Hayter @Marahayter]

@ahenryokc Can she do this if active partnership discussions ongoing (potentially) ?

[Chris Hayter @Marahayter]

@rikdog47 @nanalyzetweets Are you aware of the usp of @CRBU?

[Chris Hayter @Marahayter]

@dadbodfamilyguy If a dilution occurs it will be a disgrace given the language used in various updates.

[Chris Hayter @Marahayter]

Like the increased volume $crbu

[Chris Hayter @Marahayter]

@ahenryokc ✅ Pipeline streamlined
✅ Costs reduced
✅ Focus narrowed to vispa-cel & CB-011
✅ FDA-aligned Phase 3 path established
✅ Strong clinical data emerging
✅ Runway into 2H 2027

[Chris Hayter @Marahayter]

The more I look at this company and current SP, the more I think you trust your instincts and fill up. Market cap of just over 150 million bearly covers cash position. The Allogenic story is compelling...they have the results so far to make it work.. $crbu

[Chris Hayter @Marahayter]

@ahenryokc I hear you...sp has been awful and there seems to be very few takers at the moment. But fundamentals and all the tidying up the company has been doing hints that something positive around the corner...